Informing the Product Development of an mHealth Solution for People with Multiple Sclerosis Through Early Health Technology Assessment

Conference Paper (2022)
Author(s)

G. Giunti (University of Oulu, TU Delft - Human Factors)

Jari Haverinen (University of Oulu)

Jarmo Reponen (University of Oulu)

Research Group
Human Factors
Copyright
© 2022 Guido Giunti, Jari Haverinen, Jarmo Reponen
DOI related publication
https://doi.org/10.3233/SHTI220258
More Info
expand_more
Publication Year
2022
Language
English
Copyright
© 2022 Guido Giunti, Jari Haverinen, Jarmo Reponen
Research Group
Human Factors
Pages (from-to)
1042-1043
ISBN (electronic)
9781643682648
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

The potential of mHealth is enormous for chronic conditions, yet the integration of these technologies into the clinical infrastructures and healthcare pathways remains an ongoing challenge. Digi-HTA has been developed to support health technology assessment activities for novel digital healthcare technologies. The use of Early Health Technology Assessment (EHTA) can help product development. The present study describes the way in which EHTA can guide the development of a product to anticipate future needs and market access.